Véronique Delmas

9PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersCancer diagnosisMolecular targetsCancer geneticsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 14, 2026
MICAL2 as a key effector of β-catenin signaling driving melanoma progression and therapeutic resistance.

|Feb 24, 2026
[Melanoma and estrogens: A revolution in understanding metastatic mechanisms].

Véronique Delmas, Lionel Larue

|Jul 14, 2025
Publisher Correction: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin.

Jérémy H Raymond, Zackie Aktary, Marie Pouteaux

|Jun 11, 2025
Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin.

Jérémy H Raymond, Zackie Aktary, Marie Pouteaux

|Feb 15, 2022
Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma.

Jérémy H Raymond, Zackie Aktary, Lionel Larue

|Dec 08, 2021
Stabilization of β-catenin promotes melanocyte specification at the expense of the Schwann cell lineage.

Sophie Colombo, Valérie Petit, Roselyne Y Wagner

Pageof 2

Frequent Collaborators

7 joint publications

Lionel Larue

5 joint publications

Jérémy H Raymond

4 joint publications

Irwin Davidson

2 joint publications

Zackie Aktary